美康生物
(300439)
| 流通市值：28.91亿 | | | 总市值：37.96亿 |
| 流通股本：2.92亿 | | | 总股本：3.84亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 387,900,031.4 | 571,573,225.51 | 571,675,507.84 | 657,565,249.17 |
| 交易性金融资产 | 624,496,547.31 | 470,846,461.54 | 255,756,930.68 | 265,430,440.41 |
| 应收票据及应收账款 | 649,745,288.19 | 613,594,252.64 | 609,299,374.41 | 581,394,036.6 |
| 应收账款 | 649,745,288.19 | 613,594,252.64 | 609,299,374.41 | 581,394,036.6 |
| 应收款项融资 | 551,422.36 | 917,547.72 | 709,225.13 | 205,219.79 |
| 预付款项 | 29,861,692.03 | 33,258,713.24 | 40,168,337.39 | 38,751,364.63 |
| 其他应收款合计 | 9,163,627.64 | 10,972,385.44 | 11,726,143.72 | 10,882,782.75 |
| 存货 | 268,145,323.44 | 228,127,493.73 | 250,580,051.31 | 231,069,707.07 |
| 一年内到期的非流动资产 | 10,857,745.68 | 10,331,254.82 | 64,065,529.58 | 61,794,649.89 |
| 其他流动资产 | 38,176,764.17 | 43,188,321.87 | 42,426,138.06 | 45,576,115.45 |
| 流动资产合计 | 2,018,898,442.22 | 1,982,809,656.51 | 1,846,407,238.12 | 1,892,669,565.76 |
| 非流动资产: | | | | |
| 长期应收款 | 5,100,971.21 | 6,747,915.49 | 8,617,683.36 | 10,466,137.4 |
| 长期股权投资 | 163,670,845.91 | 163,269,443.83 | 158,036,159.79 | 158,350,888.99 |
| 其他权益工具投资 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 投资性房地产 | 215,123,554.31 | 214,406,825.86 | 166,340,169.71 | 167,473,309.59 |
| 固定资产 | 1,059,334,859.54 | 1,083,156,520.45 | 1,140,082,998.89 | 1,149,884,976.33 |
| 在建工程 | 33,179,337.5 | 26,555,338.1 | 25,922,853.38 | 20,816,621.34 |
| 使用权资产 | 31,921,251.26 | 32,956,774.58 | 36,890,827.44 | 39,394,327.59 |
| 无形资产 | 111,746,975.78 | 115,589,760.32 | 123,697,491.44 | 126,886,756.12 |
| 长期待摊费用 | 25,344,599.61 | 27,096,842.48 | 27,236,490.72 | 29,748,082.89 |
| 递延所得税资产 | 53,126,672.34 | 51,413,352.24 | 55,476,923.1 | 52,765,179.26 |
| 其他非流动资产 | 246,466.9 | 241,586.9 | 358,607.59 | 242,340.69 |
| 非流动资产合计 | 1,703,795,534.36 | 1,726,434,360.25 | 1,747,660,205.42 | 1,761,028,620.2 |
| 资产总计 | 3,722,693,976.58 | 3,709,244,016.76 | 3,594,067,443.54 | 3,653,698,185.96 |
| 流动负债: | | | | |
| 短期借款 | 60,000,000 | 60,000,000 | - | 20,000,000 |
| 应付票据及应付账款 | 336,450,920.67 | 357,658,644.85 | 329,594,618.67 | 356,412,011.53 |
| 其中：应付票据 | 20,252,181.01 | 19,180,725.31 | 20,153,715.2 | 23,766,588.28 |
| 应付账款 | 316,198,739.66 | 338,477,919.54 | 309,440,903.47 | 332,645,423.25 |
| 合同负债 | 50,948,584.78 | 56,520,722.75 | 48,387,533.4 | 55,846,702.15 |
| 应付职工薪酬 | 62,247,348.56 | 50,794,490.82 | 44,844,788.58 | 73,925,129.94 |
| 应交税费 | 14,014,838.45 | 11,224,180.2 | 13,524,242.67 | 19,036,305.01 |
| 其他应付款合计 | 72,400,076.58 | 81,688,030.61 | 76,242,373.97 | 76,786,329.81 |
| 应付股利 | - | 5,326,019.94 | - | - |
| 一年内到期的非流动负债 | 12,116,226.46 | 11,885,429.64 | 11,918,368.3 | 11,480,010.57 |
| 其他流动负债 | 10,151,310.8 | 10,711,681.69 | 9,493,844.11 | 10,499,109.15 |
| 流动负债合计 | 618,329,306.3 | 640,483,180.56 | 534,005,769.7 | 623,985,598.16 |
| 非流动负债: | | | | |
| 租赁负债 | 19,761,715.66 | 22,697,016.34 | 26,252,130.2 | 27,744,552.23 |
| 预计负债 | - | 1,371,513.27 | 1,371,513.27 | 1,371,513.27 |
| 递延收益 | 25,890,000 | 24,550,000 | 25,756,666.72 | 25,963,333.38 |
| 递延所得税负债 | 22,850,555.57 | 22,784,318.01 | 25,522,350.08 | 26,999,590.26 |
| 非流动负债合计 | 68,502,271.23 | 71,402,847.62 | 78,902,660.27 | 82,078,989.14 |
| 负债合计 | 686,831,577.53 | 711,886,028.18 | 612,908,429.97 | 706,064,587.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 383,843,815 | 384,318,815 | 384,318,815 | 384,318,815 |
| 资本公积 | 1,118,635,337.26 | 1,120,311,483.32 | 1,120,311,483.32 | 1,121,072,087.26 |
| 减:库存股 | - | 2,911,750 | 2,911,750 | 2,911,750 |
| 其他综合收益 | -17,152,467.16 | -17,331,577.01 | -17,576,378.9 | -17,952,197.64 |
| 盈余公积 | 134,591,669.5 | 134,591,669.5 | 134,591,669.5 | 134,591,669.5 |
| 未分配利润 | 1,420,251,221.61 | 1,384,362,743.7 | 1,368,862,415.24 | 1,335,096,052.96 |
| 归属于母公司股东权益合计 | 3,040,169,576.21 | 3,003,341,384.51 | 2,987,596,254.16 | 2,954,214,677.08 |
| 少数股东权益 | -4,307,177.16 | -5,983,395.93 | -6,437,240.59 | -6,581,078.42 |
| 股东权益合计 | 3,035,862,399.05 | 2,997,357,988.58 | 2,981,159,013.57 | 2,947,633,598.66 |
| 负债和股东权益合计 | 3,722,693,976.58 | 3,709,244,016.76 | 3,594,067,443.54 | 3,653,698,185.96 |
| 公告日期 | 2026-10-28 | 2026-08-29 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |